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Abstract 
Traditionally, physicians rely on medical knowledge learned or acquired through practice 
to make a correct decision in diagnosis of diseases and affected medications. Progress in 
knowledge base systems and related Information Technology changed this situation by 
providing huge amount of medical information that can support physicians in the decision 
making. Integrating this great amount of information to retrieve the superlative results is 
however a demanding job. By introducing the concepts of Semantic Web, the sources of 
medical knowledge have amended to acquire the advantages of this concept and its 
technologies in gathering and representing the information and recommending superior 
decision from comprehensive information. Particularly, ontologies are recognized to 
enhance the efficiency of information management significantly and improve the 
dependability of communication especially when heterogeneous actors and diverse 
environments are involved. 
In this thesis, various Semantic Web techniques have been employed to support data 
integration to assist physicians in the process of drug recommendation. The thesis 
proposes a novel approach for supporting drug recommendation decisions by modeling a 
Semantic Web-based infrastructure correlating comprehensive medical knowledge which 
allows making ontology inferences and knowledge discoveries. In this work, we devise a 
Disease-Drug Ontology (DDO), an ontological model which demonstrates relations 
between human diseases and their relevant drugs and medications. The DDO, formalized 
in OWL, allows the integrated representation of various sources of ontologies and data 
schemas and overcomes the heterogeneity problem among these different sources by 
applying proper matching techniques. An automated reasoning is performed over the 
ontology using a Description Logic Reasoner in order to validate the DDO. Our model is 
also composed of an ontology crawler that provides physicians, by direct queries from 
DDO, to facilitate the process of making decisions for accurate drug recommendation. 
More importantly, our system consists of a unique rule-based inferential engine 
employing drug rules and patient data for the purpose of suitable drug recommendation. 
In order to prototype the key services of the system and reveal the validity of our 
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semantically integrated Disease-drug knowledge base, some case studies are provided 
and the obtained results are very promising.  
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INTRODUCTION 
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1.1 Motivation  
Prescribing the correct and proper medications for humans’ diseases is one of the tough 
challenges that physicians and healthcare clinicians may face every day. This is not only 
because of the various and numerous number of diseases and their available drugs, but 
also due to the lack of a unified documentation in the healthcare system. Most of the 
information in the health care system is paper-based which causes a limited coordination 
of data and services. Information in the medical domain lives on islands, which results in 
raising costs and increasing medical errors. In order to make the right decision to 
recommend effective treatment, a general physician must carefully investigate a patient’s 
medical history, his diagnosis and the diverse aspects of the relevant medications. 
Although, most physicians obtain this proficiency after gaining a few years of experience, 
estimates show that 1.5 million people are harmed every year from preventable mistakes 
in prescribing and administering medications in the United States alone [1]. Information 
insights coupled with clinical collaboration can dramatically improve the quality of the 
process of drug recommendation, patient safety and outcomes, while also being quite cost 
effective.  A smarter drug recommendation system starts with better connections, better 
data and faster and more detailed analysis. Thus, a forecasting informatics model that can 
develop data capture, integration and recommendation of suitable medication based on 
integrated medical knowledge around drugs and diseases is highly desirable.  To achieve 
this, data across knowledge domains of drugs and diseases needs to be linked in an 
adequately standardized manner to permit efficient inferences. Linking the heterogeneous 
data from various sources of medical knowledge is a fundamental challenge. Moreover, 
lacking a well-defined data framework can obstruct the inference capability of the model. 
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It is thus essential to overcome these limitations during the development of our proposed 
model in order to reach a medical infrastructure that can handle data complexity, 
represent both semantic and logic relationships and allow interoperability in a global 
manner. The development of Semantic Web and knowledge representation technologies 
offers a promising platform that can broadly integrate heterogeneous data while dealing 
with semantics and complexity of knowledge interoperability.  
Our goal is to employ medical knowledge and semantic concepts to integrate and 
represent disease and drug relevant entities and the complex relationships among them 
based on the clinical and therapeutic aspects to assist physicians in identifying novel 
suitable medications for drug recommendation. In this work, we design and build a 
semantic web-based infrastructure by associating comprehensive medical information in 
the domains of drugs and diseases which allows ontology inference and knowledge 
discovery to aid in selecting the appropriate medications for the diagnosed diseases. 
1.2 Thesis Contribution 
We implement a proactive drug recommendation system that could analyze and suggest 
the potential available drugs for diseases based on integrated medical/clinical knowledge 
around drugs and diseases. The system is also capable to suggest suitable drug doses and 
potential interactions of drugs with the active medications of the patient. The system is 
built based on the semantic web approach and its technologies to integrate the disease-
drug information for revealing the suitable drug recommendation of diagnosed diseases. 
The proposed ontology in this work is considered as one of the pioneering ontologies 
which bring drugs and diseases together based on their therapeutic aspects. Furthermore, 
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the system shows the great amount of extensibility and adaptability due to applying the 
reliable and dependable sources of knowledge in developing the proposed ontology.  The 
recommended semantic web framework is designed to allow evolving and querying the 
information quickly and thoroughly. The system also provides the capability to handle 
flexible and complex queries and to allow inference across the related features of drugs 
and diseases.  
1.3 Thesis Outline  
The rest of the thesis is organized as follows. Chapter 2 outlines some basic background 
of Semantic Web technologies such as the Extensible Markup Language (XML), 
Resource Description Framework (RDF), Web Ontology Language (OWL) and 
Ontology. It also reviews former approaches in drug recommendation and medical 
knowledge representation field. Chapter 3 presents the influence of ontology on the 
domain of medical knowledge, and then explains the overall system architecture. 
Afterward, it focuses on describing our attempt in building the ontology framework 
including the design, structure and examples of key entities and properties formalized in 
OWL. Chapter 4 introduces the concept of ontology matching and reviews a variety of 
classifications of matching techniques. Then it explains how these techniques applied in 
construction of our ontology framework. Chapter 5 describes the process of validation of 
ontology framework via a Description Logic Reasoner. Subsequently, it presents the role 
of query engine and rule-based inference engine in our system and how they are 
implemented. Chapter 6 portrays some kinds of potential results of query engine and 
provides some case studies to demonstrate the validity of our semantically integrated 
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Disease-Drug knowledge base for revealing reliable drug recommendations. Chapter 7, 
the last Chapter, summarizes the work and provides some perspectives on future 
development to improve the quality and reliability of drug recommendations and enhance 
the robustness of the infrastructure. 
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7 
 
This Chapter discusses the fundamental technical background of ontology and overviews 
the related research work in this field. In order to understand the ontology more 
profoundly it is essential to first understand the semantic web on which it relies.  
2.1 Semantic Web 
The World Wide Web which is basically written in Hyper Text Mark-up Language 
(HTML) is designed to be understood and interpreted by humans. Gradually by 
increasing the amount of available data on the current web, the process of finding, 
organising, accessing and maintaining the information for the users turns to be extremely 
difficult. Therefore this notion comes up that by shifting the retrieval of data from users 
to the computers, the web can be optimized and become much more goal based rather 
than task based. Such a desire leads to the concept of semantic web which is brought up 
to enhance some of the weaknesses of the current web. The term semantic web is 
introduced by the inventor of World Wide Web, Tim Berners-Lee. The idea behind that is 
to extend the capabilities of the current classic web of documents and create a web of 
data that can be accessed and processed directly or indirectly by machines, devices and 
computers in addition to users [2-4]. The ultimate goal of semantic web is to provide a 
common framework that allows data to be shared and reused across applications, 
enterprises and community boundaries and enables computers and people to work in 
mutual cooperation [3, 5]. 
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2.2 Semantic Web Architecture and Concepts 
The architecture of semantic web is composed of multiple layers (Figure 2.1). At the 
most basic level, semantic web is dependent on the Unicode and Uniform Resource 
Identifier (URI) which is simply a web identifier. Unicode is a standard for encoding a set 
of characters. By using such a standard form, all human languages can be written and 
read on the web. URI is a sequence of characters which provides a standard form to 
identify the resources [6-8]. 
 
Figure 2.1: Semantic Web Architecture 
Extensible Markup Language (XML) constructs the second layer of semantic web 
architecture. XML is a form of markup language much like HTML that has been 
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employed on the web since its foundation; however unlike HTML, there is no set of 
predefined tags in XML. Instead, the beauty of XML lies in the fact that it is extensible 
and tags can be defined and utilized as required by the specific application. In addition to 
the difference mentioned, XML is designed to carry data in comparison to HTML which 
is used to display data. Another advantage of XML is that it is a self-descriptive language 
which can be used between different platforms and programming languages and still 
expresses complex messages and functions [3, 9, 10].  XML Schema restricts the 
structure and content elements of XML documents. The World Wide Web Consortium 
(W3C) recommends XML namespaces which are applied to offer uniquely named 
elements and attributes in a XML document. In the semantic web architecture, XML 
layer with XML namespace and XML schema certify that the common syntax is used in 
the semantic web [11]. 
The other important technology for developing the semantic web is the Resource 
Description Framework (RDF). RDF which was initially designed as a Meta data model 
is a framework for describing information and resources on the web. Putting information 
into RDF files, makes it feasible for computer programs to search, discover, pick up, 
collect, analyze and process information from the web. Since RDF documents are written 
in XML, they can easily be exchanged among different types of operating systems and 
application languages. RDF is based on statements which are known as triples. Each 
triple includes three main parts of subject, predicate and object like a sentence in natural 
languages. Therefore each triple can be modeled as a graph with two nodes of subject and 
object that are connected by the edge of predicate [5, 11, 12, 13]. 
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Figure 2.2 illustrates the RDF graph of Coronary Heart Disease and one of the drugs that 
it may be treated by.  
The subject represents the resource itself and must be defined by URI. The predicate 
which is a relationship is also a URI since each relationship has a standard definition that 
is expressed through its unique URI. The object which is the resource or state that is 
being related to is considerable because it can be defined as a URI or a literal value. RDF 
itself is just a description of graph formed by triples. RDF Schema (RDFS) extends RDF 
vocabulary to allow describing taxonomies of classes and properties which provides 
major elements of the description of ontologies [13-14]. 
 
 
Figure 2.2: RDF Graph for a disease and its possible drug 
The next fundamental layer of semantic web architecture is Web Ontology Language 
(OWL) that can be compared to a grammar system of the Semantic Web. OWL roots are 
in description logic and its foundational goal is to bring the reasoning power of 
description logic to the semantic web. OWL which is built on top of the RDF also 
provides additional standardized vocabulary, superb machine interoperability and a well-
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defined syntax which is much stronger than RDF [11, 15]. Mentioned specifications 
make OWL a suitable language to be employed explicitly for development of an ontology 
which is a demonstration of concepts and their relationships. Ontology is discussed in 
more details further in section 2.3. 
Based on various range of compatibility and restrictions, OWL comes in three distinct 
categories of OWL Lite, Web Ontology Language Description Language (OWL DL) and 
OWL Full. OWL Lite is the most restricted one. It is the simplest OWL sublanguage 
which can be used for classifying resources in a hierarchical form. OWL Lite is quite 
useful when an uncomplicated OWL system is required with limited resources or limited 
speed. OWL DL is a more comprehensive system which comes with greater potential and 
more flexibility, while still being possible to implement and use consistently. OWL DL is 
designed for full description logic which offers decidability of reasoning systems. It also 
allows for more complicated analysis, classification, more complex relationships and 
properties than OWL Lite. OWL Full is the final level of complication which is 
theoretically unlimited model, where relationships and classifications can be widely 
expanded with a great deal of complexity. It mostly targets the users who seek maximum 
expressiveness and syntactic freedom of RDF with no computational guarantees. OWL 
Full can fully support OWL DL and OWL Lite systems, although it is impossible to 
predict and implement correctly. The ontology developers must select OWL specie that 
best suits their needs. [11, 15, 16, 17] 
The role of the Logic layer is to support a powerful logical language for making 
inferences that make the semantic web expressive enough to aid us expansively in 
various situations. All the semantics and rules are executed at the layers below Proof and 
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the result will be used to confirm the reasoning. The top layers of semantic web 
architecture express both the proof and the trusted data together to demonstrate that the 
results are trustworthy. In order to make inputs reliable, cryptography means such as 
digital signatures can be used. A user interface application can be built on the top of all 
these layers. [11, 18] 
2.3 Ontology 
The term ontology initially comes from philosophy in which it is a theory about the 
nature of existence. In the context of knowledge sharing ontology is an explicit 
specification of a shared conceptualization of a domain of interest. From the view of 
computer science and artificial intelligence, ontology represents a domain of knowledge 
or discourse as a set of concepts (classes), their attributes (properties), instances of those 
concepts (individuals) and the relationships in which classes and individuals can be 
related to one another [5, 19]. Implementation of ontology is the heart of all semantic 
web based knowledge representation. OWL is the language that is recommended by W3C 
Semantic Web standard for encoding the ontologies [17]. 
While database schema models data at the physical or logical level, ontology is known 
for modeling the knowledge in the semantic level. Therefore, it performs a vital task in 
representation of a particular domain which allows for automatic reasoning and 
interpretation with applicable semantic context. Based on its independence from the 
lower levels of data models, ontology is capable of integrating and sharing data between 
heterogeneous information resources and specifying interfaces to independent, 
knowledge-based services. While offering advantages to facilitate interoperability among 
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multiple heterogeneous systems, ontology also provides services for answering queries 
and reusing knowledge resources [3, 19, 20]. In other words, ontology can be used as a 
way of communication between the human being and a system or system-to-system. 
Ontology can be used in information retrieval and knowledge management. The more 
perfect the framework of domain ontology is; the more accurate information can be 
provided [21]. 
Since the construction of ontology from scratch is a very time consuming task, ontology 
developers try to reuse existing ontologies whenever possible. However, handling 
complex ontologies that are constructed from multiple knowledge domains also brings 
another issue up that needs to be addressed by ontology engineering. Further details 
regarding ontology engineering and its relevant concepts are described in Chapter 4. 
2.4 Related Works 
During last two decades, the development of semantic web and ontology has had a great 
impact on knowledge representation. This is highly significant especially when the 
knowledge can be applied to do some reasoning as part of a decision support system [22]. 
The medical and biomedical domain is also not an exception and developing of semantic 
web can have dramatic improvements on this area of knowledge. Semantic web 
framework can help organize, query and evolve the enormous amount of information in 
these fields quickly and thoroughly. Although much research has been conducted recently 
on generation of medical ontologies based on the semantic web, most of them have been 
focused on differential diagnosis of diseases either specific or general. Hence, the 
systems that are developed from the aspect of drug recommendation in the domain of 
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medical knowledge are very limited [23]. Some of existing systems in this field are 
discussed in the following paragraphs. 
T.M. Swe et al. in [24] have proposed a case based reasoning methodology for querying a 
diagnostic knowledge base using ontology on diagnosis of the tuberculosis (TB) disease 
and recommending the relevant treatments. Their system consists of two main 
components: domain ontology and a case-based reasoning module. Their domain 
ontology contains case knowledge, concepts used to describe cases and relationships 
between the concepts. This domain ontology can be considered as a disease ontology 
that, in their case, only contains the information about tuberculosis (TB) disease.  Case-
based reasoning module is based on a technique to retrieve the previous similar cases’ 
information and reuse them to solve the new case’s problem. The new solution for the 
new case can be revised and also retained as a new case in the system.   
Nevertheless, one of the main problems of their approach is that it cannot be expanded 
easily to all diseases; hence, the ontology is only made for the treatment of tuberculosis 
(TB) disease and it is not considered as a standard ontology. Besides, suggestion of 
treatment based on the previous cases, alone, cannot satisfy all cases in the area of 
medical knowledge. Therefore the reliability and applicability of the system is vastly 
limited.  
R.C. Chen et al. in [25] have developed a recommendation system for anti-diabetic drugs. 
The purpose of their study is to aid the physicians to make a right decision in selecting 
the anti-diabetic drugs. They have constructed two separate ontologies in their work: 
patient data ontology and anti-diabetic drugs ontology. Patient data ontology is applied to 
store personal information, history and test results of the patients and anti-diabetic drugs 
15 
 
ontology has been designed to be used as the source of medicine knowledge. Based on 
the results of some tests such as liver function test, glucose level of the patient, and the 
medicine knowledge in the anti-diabetic drugs ontology, they have applied some rules to 
their rule engine. The final result of the rule engine is considered as the drug 
recommendation for the diabetic patients. Although their system can be applied as drug 
recommendation system for diabetic patients, but it has a poor capability to be 
generalized to other diseases and to be applied in a real system. The assumption of the 
system is based on one disease and no part has been designed for analyzing different 
diagnoses. The use of some reliable resources such as the American Association of 
Clinical Endocrinologists data in the construction of ontology [25] is a positive point, 
however since their ontology have been built from the scratch, its development into more 
applicable one is still an extremely  time-consuming task. 
An ontological system for chronic disease management based on the electronic medical 
records has been offered by A.M. Iqbal et al. in [26].  Their proposed ontology is 
comprised of Computer-based Patient Record (CPR) [27] Ontology which is augmented 
by mapping some concepts from the Electronic Health Record (EHR) Model and Chronic 
Disease Management (CDM) Model into it. Since their ontology is built in OWL-DL, the 
decision support system can be implemented through reasoning based on the description 
logic. The system is mostly patient centered and focuses on the diagnosis of chronic 
diseases. According to their results, they were not able to capture the medication into 
their ontology. Although, they do not offer any treatment for the chronic diseases in their 
ontological system, however, the idea of mapping and alignment between concepts of 
different source of knowledge can be extracted from their work.  
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M. Hadzic et al. in [28] have designed an ontology-based approach to gain support for 
research into genetic human diseases. Their proposed ontology represents the information 
in four categories including types of diseases, symptoms, genetic and environmental 
causes and treatments that might be available such as drug therapy, physiotherapy, 
surgery, etc. The components of their ontology are mainly based upon the biomedical 
aspects and the relationship of genome and genes to diagnostics of diseases. Therefore, it 
cannot be referred to when the clinical aspects of diseases and drugs are willing to be 
considered more. Besides, the treatment category of their ontology is very general and 
cannot lead to a drug recommendation for a patient. No reasoning has been done on the 
ontology in this work to demonstrate the support of the rule engines for the proposed 
ontology.  
A.X. Qu et al in [29] have developed a semantic structure that helps in discovering 
treatments for a disease from drug entities that are already approved for another disease. 
They have striven to make relationships between the pharmacological aspects of drugs 
and knowledge of biological systems and disease processes in their proposed semantic 
infrastructure. This work is done based on the design of Disease-Drug Correlation 
Ontology (DDCO). The developed DDCO which is formalized in OWL integrates 
multiple ontologies, vocabularies and datasets that extracted from pharmacological and 
biological domains. Their knowledge framework which is capable of interconnecting 
drug actions and disease mechanisms across biological contexts demonstrates a great 
flexibility for data mining and reasoning across the range of human diseases. Although, 
their system recommends a great structure of relationships between drugs and diseases, 
however, it is mainly focused on the chemical and pharmacological aspects of drugs and 
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it can be specifically applied in the process of discovery of drug development. The 
proposed system in this thesis is mainly concentrated on the therapeutic and clinical 
aspects of drugs which can be applied as a drug recommendation system.  
The system that has been modeled by A. Rodriguez et al. in [23] is the most similar 
system to the one that is proposed in this thesis. Their system is initiated to assist the 
clinicians with drug prescription. In their system, physicians are required to enter the 
diagnosis and allergies of the patient manually, and then system returns the possible 
drugs that match with that diagnosis. The architecture of the system includes ontology 
that is constructed by the developers of the system which consists of three classes of 
diseases, medicines and allergies and the relationship between these concepts. In next 
step, the offered ontology is queried through Jena which results in the outcome of their 
system. Jena is a query engine that is introduced in Chapter 5. Their system has some 
defects that are corrected in the proposed approach of this thesis. Since their ontology has 
been designed from scratch, the development of such a system into a real system that 
includes all the diseases and drugs in the medical domain is an enormously time 
consuming task. The proposed approach in this thesis has fixed this problem by using the 
standard valid ontologies and authentic data bases in the medical domain. Their ontology 
is just limited to three components, which affects the reliability of the output of the 
system. During the process of drug recommendation, there are many other aspects that 
need to be considered such as age of the patient, some test results and the interactions of 
drugs. The proposed ontology of this thesis is concerned about these various features in 
order to recommend the suitable drug. Therefore our approach can provide more accurate 
real time results. In our approach all the information about the patient is retrieved from 
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the patient database automatically, which has not been offered in [23]. We also extend the 
outcome of our work by employing a rule engine in addition to the Jena query engine. 
The rule engine allows for more complicated queries based on the various rules that are 
defined across the ontology which leads the system into more realistic results. 
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This Chapter presents the overall architecture of the proposed system and provides a 
detailed description of its main components. It first describes the impact of ontology on 
the domain of medical knowledge. Then presents the whole architecture of the proposed 
system and finally focuses on describing our effort in developing the ontology framework 
which can be considered as the heart of our system. The novelty of the approach is that it 
not only integrates authentic knowledge sources for the disease and drug entities, but it 
also deals with the semantic interoperability among these sources. A premise to achieve 
this is a knowledge framework representing medical entities and relations among them 
which enables inference extractions.   
3.1 Ontology in Medicine 
Traditionally the base of the medical knowledge has been located in the heads of 
experienced doctors, the ones who have dedicated years of training and practice in order 
to make correct decisions in diagnosis of diseases and their effective treatments [24, 28]. 
This practice worked well in the past when production of the new data needed huge 
amount of effort and the flow of the new data was not as great as to overwhelm the 
experts. New modern experimental techniques changed this situation quickly by 
providing huge amount of information. During the last few decades this information has 
been collected and evaluated in different databases and by now a great amount of medical 
knowledge can be accessed via Internet [28]. Assimilating this great amount of 
information to retrieve the best results is impossible for humans; therefore by introducing 
the concepts of semantic web and ontology in the World Wide Web, the sources of 
medical knowledge have also altered to get the benefits of these concepts in storing and 
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representing their information. Currently, it is extensively accepted that ontologies can 
make a major contribution to the design and implementation of information systems in 
the medical field [30]. Ontology can be indeed useful in medicine where it can enhance 
the efficiency of information management dramatically and improve the reliability and 
consistency of communication, especially when heterogeneous actors and different 
environments are involved. 
The use of ontology in medicine is mostly concentrated on the representation of medical 
terminologies. Physicians developed their own particular languages and lexicons to assist 
them in gathering and communicating general medical knowledge and patient-related 
information proficiently. This language was appropriate for keeping, processing and 
spreading the records of knowledge on paper or similar media. However, the paper-based 
terminology systems is not able to fulfill the new expectations of healthcare information 
systems anymore, such as the demand for reuse and sharing of patient data, or 
communication of complicated and comprehensive medical concepts that was possibly 
expressed in different languages. Accomplishment of such a task demands a deep 
analysis of the structure and concepts of medical terminology. Such analysis can be 
achieved by assuming an ontological approach for representing medical terminology 
systems and integrating them in a medical ontology [30]. Although terminologies are an 
excellent starting point for the ontology construction, they are quite different from 
ontologies. Terminologies are static structures used for knowledge reference, while 
ontologies are created to be applied in knowledge inference and reasoning [22]. Unified 
Medical Language System (UMLS) can be considered as an example of terminology 
which contains many clinical terms and integrates about 100 different vocabularies [31]. 
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It is currently considered as a major reference for medical terms. The following 
ontologies can be considered as known ontologies in the medical domain: 
 NCI Thesaurus (National Cancer Institute Thesaurus) [32]: an ontology 
vocabulary that includes broad coverage of the cancer domain, including cancer 
related disease, anatomy, genes and drugs. 
 ICD-10 (the tenth version of International Classification of Diseases): An 
international standard used to classify diseases and other health problems adopted 
by World Health Organization (WHO) [33]. 
 Human disease Ontology (DOID): an open source ontology for the integration of 
biomedical data that is associated with human diseases [34, 35]. 
Creation of medical ontologies also brings great advantages to the health care system. 
Ontologies can be utilized to build more powerful and more interoperable information 
systems in healthcare. In addition they can support the need of the healthcare process to 
transmit, re-use and share patient data. Besides all above, possibly the most significant 
benefit that ontologies may bring to healthcare systems is their ability to support the 
indispensable integration of knowledge and data [30]. 
In spite of all the advances in the construction of medical ontologies, most of standard 
medical ontologies are built as a single domain-specific ontology. Unfortunately, there is 
no credible medical ontology that makes relations between various domains of drugs and 
diseases based on their clinical and therapeutic aspects. Furthermore, some ontologies 
such as NCI Thesaurus that includes both domains, only focuses on a specific category of 
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diseases and its related drugs which clearly cannot serve the purpose of drug 
recommendation for diverse category of diseases. 
3.2 Overall System Architecture 
This section explains the overview of the system architecture and the main software 
components for setting up our system environment. Figure 3.1 describes our proposed 
model for the drug recommendation system which is composed of three subsystems: the 
ontology crawler unit, the ontology rules manager and the ontology reasoning unit.  
The ontology crawler unit consists of the ontology and a query engine that connects the 
ontology to the Java platform which allows querying the ontologies directly. Our model 
contains two ontology crawlers, one for the Disease-Drug Ontology (DDO) and another 
one for the Patient Ontology (PO). Java is the main programming language in our system. 
An IDE (Eclipse SDK 3.3.1) is used as software development platform. System uses 
Protégé 3.4 Beta for ontology editing and knowledge acquisition purposes. Jena API, 
which is a Java-based framework for building semantic web applications, is used as a 
query engine of our ontology crawler. It is used to read the ontology framework and to 
create prerequisite individuals. 
The ontology rules manager, which sets the rules based on ontology knowledge and the 
facts from other sources, works with rule engine to provide knowledge rules. Finally the 
ontology reasoning unit contains a rule engine that infers some facts by applying rules on 
the existing facts. The OpenRules is used as rule engine in our system that is described 
further in Chapter 5. In our model patient database feeds the patient data into the rule 
engine and rules manager also feeds the Drug Rules into it. The system uses Apache-
24 
 
Tomcat 6.0.14 to show the final results of rule engine which can be manually started and 
stopped.  
 
 
Figure 3.1: System Architecture 
As shown in Figure 3.1, in our proposed model, first, physicians diagnose the relevant 
diseases; then DDO can be queried based on the physicians’ diagnosis to show the 
general medical knowledge about the possible drugs for the relevant diseases. Meanwhile 
the physicians are able to provide other relevant patient data with the aid of the PO. The 
results of these queries can be transferred to the patient file, but the final result of the 
system as a drug recommendation system is shown after applying the rules via our rule 
engine. Besides the effect of medical knowledge in the DDO on drug recommendation, 
there are always some medical facts that may be created or updated by the physicians or 
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pharmacists which may also affect drug selection. To apply these medical facts, we need 
to transform them into rules which are called Drug Rules in our system. These rules and 
data from patient database feed the rule engine, and then the rule engine offers a drug 
recommendation based on data and rules. Ultimately the recommended prescription made 
by rule engine can be confirmed, changed or rejected by physicians and the patient file is 
updated based on the physician’s decision. 
3.3 Design of Disease-Drug Ontology  
The first step in modeling our system is to develop a base for building our ontology. 
Ontologies can be classified into three major categories: upper-level ontology (general 
model to represent great range of tasks, domain, and application areas), domain-specific 
ontology (representing conceptualization of a specific domain), and application and task 
ontology (suitable for specific applications) [36], as shown in Figure 3.2. Accurate results 
for drug recommendation can only be made when a good knowledge base is available. 
Therefore, an ontology framework is required which contains the broad and 
interdisciplinary range of concepts of drugs, diseases and the relationship between them 
in clinical domain. Although, there are various well-accepted ontologies available in 
medical areas, most of them are built as a single domain-specific ontology which 
conceivably cannot serve our purpose. Even the existing multi-domain ontologies or 
controlled vocabularies, such as UMLS (The Unified Medical Language System) [31] 
which offer a decent framework for joining some biomedical databases, lacks sufficient 
coverage for the therapeutic aspect of drugs area [37]. To the best of our knowledge there 
is no standard medical ontology that contains the large amount of knowledge for both 
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domains of diseases and drugs, and provides the therapeutic relationships between the 
two domains. Furthermore, there is not even a single domain-specific medical ontology 
that provides sufficient coverage information for the therapeutic classification of drugs.  
Therefore, we decided to build a suitable framework, called Disease-Drug Ontology 
(DDO), which can support all above features that are required for implementation of our 
system. It requires being relatively unrestrictive, having appropriate conceptualization 
level, and allowing for scalable reasoning. Consequently, our proposed ontology is the 
first ontology which puts drugs and diseases in one umbrella and makes the relationship 
between them based on clinical aspects. 
 
Figure 3.2: Modularization of Ontology Depending on the Scope 
 
We have considered that the key point in ontology development is to reuse knowledge 
components whenever possible. Thus, previously existing ontology sources were 
carefully studied to choose pertinent reusable knowledge resources to allow efficient 
knowledge mapping and sharing among independent data sources. Details for these 
sources are described in sections 3.3.2 and 3.3.3. The knowledge components from these 
sources were tested and mapped to our knowledge framework. Therefore, data from these 
sources is obviously compatible to the DDO for integration to our knowledge base. A 
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sustained effort is made to maintain high-order hierarchy of DDO to ensure flawless data 
integration. 
3.3.1 Ontology Development Tools 
There are over 50 ontology editing environments available to aid ontology development, 
such as Protégé, Chimaera, OilEd and DAG-Edit [38-40]. Upon surveying and testing, 
Protégé was selected as the primary tool for developing the OWL framework due to the 
following reasons: 1) Protégé is an open source, free ontology editor which maintains two 
key types of modeling ontologies via the Protégé-Frames and Protégé-OWL editors; 2) It 
provides a wide set of customizable user interface elements which allows easy access, 
hierarchical tree structure for class browsing, form interface for filling in slot values; 3) It 
supports several formats including RDF(S), OWL, and XML Schema; 4) Protégé which 
is based on Java has a great extensibility and scalability with its open modular design, 
which allows convenient functionality extension by adding or creating plug-ins; 5) Such a 
plug-and-play environment makes Protégé a flexible base for rapid prototyping and 
application development; 6) Protégé has been developed and tested for many years with a 
big group of users in bioinformatics area worldwide and with continuous support 
commitment [38-41]. 
To increase the editing capability of Protégé in supporting for ontology merging, 
mapping, comparison and improving the visualization flexibility, some additional plug-
ins are adopted besides what has been packed in Protégé, including:  
 Prompt [42]: This plug-in allows to manage several ontologies in Protégé, 
including comparing versions of same ontology, moving frames between 
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ontologies, and merging all or extracted portion of ontology into one. More details 
about Prompt and how is used in building of our system is described in Chapter 4. 
 Pellet [43]: It is a reasoner that can be called to check consistency, classify the 
taxonomy and automatically compute the class hierarchy of ontology. Pellet 
reasoner is studied further in Chapter 5. 
3.3.2 Human Disease Ontology 
The first step of our ontological development is to find a good source of clinical 
knowledge to construct the upper level ontology based on them. After evaluating some 
known resources such as MeSH (Medical Subject Headings) [44], SNOMED 
CT(Systematized Nomenclature of Medicine-Clinical Terms) [45], OMIM (Online 
Mendelian Inheritance in Man) [46], DOID, ICD-10, NCI Thesaurus and UMLS, Human 
Disease Ontology (DOID) is opted as the source of knowledge of diseases for our 
ontological design due to the following reasons. Human Disease Ontology is open source 
ontology for the integration of biomedical data that is related to human diseases. DOID 
has a formally correct, semantically computable structure. Terms in DOID are well 
defined, employing standard references. These terms are connected to well-established, 
well-adopted terminologies and ontologies that contain disease and disease-related 
concepts such as SNOMED CT, ICD-10 and UMLS. Such a combination of a 
semantically computable structure and the external references to these sources facilitates 
useful inference between dissimilar datasets by applying one or more of these standard 
terminologies to code diseases. This property makes DOID a community-accepted 
ontology of diseases for clinical research and medicine in the wide range of 
environmental, genetic and infectious diseases [34, 35, 47]. By containing 8608 classes, 
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DOID is much larger than MeSH and OMIM and should therefore provide greater 
disease coverage [34]. 
As shown in Figure 3.3 diseases in DOID are divided into eight main categories 
including disease of mental health, disease of metabolism, genetic disease, medical 
disorder, disease by infectious agent, disease of cellular proliferation, syndrome and 
disease of anatomical entity. Each of these classes has their own relevant subclasses and 
this flow continues to make all the disease classes of ontology.  
 
Figure 3.3: Human Disease Ontology (DOID) 
Obviously, due to the large size of ontology, we cannot picture all classes of the ontology 
in a diagram. In Figure 3.4, DOID ontology is shown with one level of its subclasses in 
which as we can see the class of disease by infectious agent has four subclasses of fungal 
infectious disease, bacterial infectious disease, parasitic infectious disease and viral 
infectious disease or as another example the class of disease of mental health has  
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Figure 3.4: Human Disease Ontology with one level of subclasses 
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twelve subclasses such as personality disease, adjustment disease, developmental disease 
of mental health, dissociative disease, sleep disease, impulse control disease, gender 
identity disease, cognitive disease and so on. 
In addition to the classes, Human Disease Ontology contains several object properties 
that are used to define the relationships between classes. A list of these properties is 
shown in Figure 3.5. Some of these properties such as is-a are already in use in the 
ontology, and some others such as has-symptom are defined to be used further in case of 
mapping with other ontologies. As an example, all of the eight subclasses of disease class 
are in a relationship with disease class based on is-a relationship. 
 
 
Figure 3.5: List of object properties in Human Disease Ontology 
3.3.3 DrugBank Database and Drug Ontology 
Building a drug Ontology is the other important part of construction of DDO as an upper 
level ontology. Since there is no standard ontology in the domain of drugs [29, 48, 49], it 
was decided to choose a suitable database from which a drug ontology can be built. There 
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are essentially two kinds of open source online drug databases: 1) Clinically Oriented 
drug resources such as PharmGKB (Pharmacogenomics Knowledge Base) [50], RxList 
[51] and 2) Chemically oriented drug databases include KEGG (Kyoto Encyclopedia of 
Genes and Genomes) [52] and PubChem [53]. DrugBank [54] is also another open source 
database which is developed and supported by the Departments of Computer Science and 
Biological Sciences of University of Alberta. It is extended to make a bridge between the 
clinically and chemically oriented databases. As a clinically oriented drug encyclopedia, 
DrugBank is able to provide detailed, up-to-date, quantitative, and analytic information 
regarding drugs, drug targets and the biological and physiological consequences of drug 
actions. It also contains links to most of bioinformatics and biomedical databases such as 
PubChem , KEGG and also drug and pharmaceutical databases such as PharmGKB and 
RxList. The database contains 6711 drug entries including 1447 FDA-approved (US 
Food and Drug Administration) small molecule drugs, 131 FDA-approved biotech drugs, 
85 nutraceuticals and 5080 experimental drugs [55]. Besides, DrugBank also includes 
some specific data fields such as: drug synonyms, drug brand names, drug-drug 
interactions, food-drug interactions, prices in USD and dosages, which make the database 
a perfect choice in building up the desired drug ontology. In order to employ DrugBank 
database in construction of DDO, modification of the database into appropriate ontology 
is required. For this purpose, the XML format of DrugBank database is used to convert it 
into ontology. Figure 3.6 shows part of Drug Bank database XML file for Insulin 
Glargine Drug. 
In order to transform DrugBank database into ontology, the XML-tab that is a plug-in in 
Protégé is applied. XML-tab allows importing XML file into Protégé and save it as 
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ontology in OWL format [56]. As a result after importing the DrugBank database XML 
file in Protégé, the drug ontology becomes ready for use in the construction of an upper 
level ontology. 
Figure 3.7 displays the drug ontology that contains sixteen classes including: drug, 
manufacturers, packagers, ahfs-codes, dosages, categories, groups, synonyms, food-
interactions, mixtures, external-identifiers, external-links, brands, drug-interactions, 
patents and prices. All these classes are subclasses of Thing class which is the super class 
in all OWL ontologies. 
 
Figure 3.6: Portion of Drug Bank Database XML File 
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The drug class is the center class of the ontology that all other fifteen classes are in a 
relationship with through relevant object properties. In Drug ontology some of the 
information such as DrugBank-id or name of each drug is demonstrated as a Data type 
property of that drug. Therefore Drug ontology contains some data type properties, as 
well. The list of all data type and object properties of Drug ontology is shown in Figures 
3.8 and 3.9. 
 
Figure 3.7: Drug Ontology 
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Figure 3.8: List of Object Properties in Drug Ontology 
 
 
Figure 3.9: List of Data Type Properties in Drug Ontology 
3.3.4 Disease-Drug Ontology 
Since none of the Drug or Human Disease Ontologies, individually, can meet our desired 
requirements, there is a need to employ a method to link these two main ontologies 
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together and construct an upper level Disease-Drug Ontology. Ontology matching is the 
method that is opted to make the relation between the two ontologies. Ontology matching 
and its relevant concepts are fully discussed in the Chapter 4 of this thesis. 
After extracting the Drug Ontology into the Human Disease Ontology, there is a need 
that the class of Drug is defined disjointed from the class of Disease. Making two classes 
disjointed from each other clarifies that an object cannot be an instance of more than one 
of these classes. The Disjoint Class button in Protégé editor is applied to specify the 
disjoint classes. Next step in construction of Disease-Drug Ontology is to define 
relationships between the diseases and their relevant drugs. In order to form a relationship 
among Drug and Disease classes, appropriate object properties are required to be 
selected. There is no such object property available among the properties of Drug and 
Human Disease Ontologies, hence two object properties of may treat and may be treated 
by are created to establish the relationship between Disease and Drug classes. These two 
object properties are defined as inverse of each other which means the domain of one is 
the range of the other one.  Consequently, the domain of may treat property is restricted 
to the Drug class and its range is limited to the Disease class of DDO, while the domain 
and range of may be treated by property is defined vice versa. Figure 3.10 displays a 
diagram of Disease-Drug Ontology and the added object properties.  
Using the two object properties of may treat and may be treated by; the relevant drugs of 
each specific disease can be defined. As a prototype in this thesis, the relationship 
between eleven diseases and their relevant drugs which are seventeen drugs has been 
established. For instance, six following drugs are considered for Coronary Heart Disease 
in DDO including: Acetylsalicylic acid (ASA), Clopidogrel, Heparin, Metoprolol, 
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Perindopril and Lovastatin. The list of all these eleven diseases and their medications are 
summarized in Table 3.1. 
 
Figure 3.10: Disease-Drug Ontology 
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Table 3.1: List of Diseases and their Relevant Drugs in DDO 
Disease Disease ID Drug DrugBank ID Drug ID 
Acromegaly DOID_2449 Somatropin recombinant DB00052 Drug_317 
Otitis media DOID_10754 Azithromycin DB00207 Drug_348 
Esophagitis DOID_11963 Pantoprazole DB00213 Drug_678 
Coronary heart disease DOID_3393 
Acetylsalicylic acid  DB00945 Drug_60 
Clopidogrel DB00758 Drug_285 
Heparin DB01109 Drug_701 
Metoprolol DB00264 Drug_546 
Perindopril DB00790 Drug_585 
Lovastatin  DB00227 Drug_648 
Pulmonary hypertension DOID_6432 Treprostinil DB00374 Drug_560 
Nephrotic syndrome DOID_1184 Triamterene DB00384 Drug_354 
Gastroesophageal reflux 
disease 
DOID_8534 Cimetidine DB00501 Drug_444 
Diabetes mellitus type 1 DOID_9744 Insulin Glargine DB00047 Drug_458 
Diabetes mellitus type 2 DOID_9352 
Insulin Glargine DB00047 Drug_458 
Glibenclamide DB01016 Drug_718 
Metformin DB00331 Drug_640 
Lemierre's syndrome DOID_11337 Drotrecogin alfa DB00055 Drug_88 
Human immunodeficiency 
virus infectious disease 
DOID_526 Amprenavir DB00701 Drug_117 
 
3.3.5 Patient Ontology 
The Patient Ontology that is offered in this thesis is built based on some materials from 
Meditch (Medical Information Technology, Inc.) documents [57, 58]. Meditech’s 
software and information systems are installed in health care organizations around the 
world; therefore their resources are reasonably trustworthy. The proposed Patient 
Ontology can be applied to compare physician’s decisions in similar patient cases. As it 
is shown in Figure 3.11 Patient Ontology contains four super classes including: Personal 
Information, Patient History, Patient Allergies, and Disorder class. The Personal 
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Information class consists of seventeen subclasses that are all related to the personal 
information of patients such as first name, last name, address, birth date, blood type and 
so on. Any diagnosis or injuries, family or hospitalization history is gathered in the six 
subclasses of Patient History class. The Patient Allergies class contains four subclasses 
that specify the allergic reaction, severity, status and type of allergy of the patient. The 
condition, date of diagnosis, disease’s type or name, symptoms, treatment and any other 
similar information is included in the eight subclasses of Disorder class.  
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Figure 3.11: Patient Ontology
  
CHAPTER 4 
ONTOLOGY MATCHING 
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This Chapter describes the concept of ontology matching and its related notions as a 
solution to the semantic heterogeneity problem faced by ontology models. It first presents 
the motivation and definition of the ontology matching problem, and then overviews 
various classifications of matching techniques. Finally, it introduces one of the common 
frameworks that is available for matching and translating between different knowledge 
representations and explains how matching techniques are applied in construction and 
development of the proposed Disease-Drug Ontology (DDO).  
4.1 Ontology Matching 
Since ontologies typically provide a vocabulary describing one domain of interest, one 
ontology is not enough to support most of the tasks in reality, and there is a need for 
applications to use variety of ontologies together [59]. However, linking the ontologies is 
not as simple as it may look. As each ontology defines its own set of concepts and 
relations, interoperability issues arise when exchanging information among 
heterogeneous ontologies [60-61]. In order to overcome this heterogeneity among 
ontologies and make them understand each other, a context of ontology engineering has 
been proposed. Since ontology engineering has to deal with multiple and distributed 
ontologies, it needs support of ontology matching. 
During study of ontology matching, we may confront with some other related concepts 
such as correspondence, alignment, mapping, and merging. Since in this area of ontology 
matching, different authors use different words to refer to similar concepts, and, vice 
versa, sometimes different concepts are referred to by the same name, it may seem quite 
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useful to get familiar with the general meaning and definition of each concept before 
going into the details.  
Correspondence is the relation holding, or supposed to hold according to a particular 
matching algorithm or individual, between entities of different ontologies. These entities 
can be as different as classes, individuals, properties or formulas. Some authors use the 
term mapping instead [62]. Based on the terminology defined by J. Euzenat, 
correspondence definition can be indicated as the following [63]. A correspondence 
between an entity e belonging to ontology o and an entity e’ belonging to ontology o’ is a 
5-tuple <id, e, e’, r, conf> where: 
 id is a unique identifier of the correspondence, 
 e and e’ are the entities (e.g., properties, classes, and individuals) of o and o’, 
respectively, 
  r is a relation such as “equivalence,” “more general,” “disjointness,” 
“overlapping,” holding between the entities e and e’ , and 
 conf is a confidence measure (typically in the [0,1] range) holding for the 
correspondence between the entities e and e’. 
The next key concept in the studying of ontology matching, called alignment, which is a 
set of correspondences between two or more (in case of multiple matching) ontologies. 
Basically, the alignment is the output of the matching process [64]. In other words, an 
alignment of ontologies o and o’ is a set of correspondences between entities of o and o’ 
[63]. Alignments can be used for various tasks such as ontology merging, query 
answering, data translation or for browsing the semantic web.  
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Mapping is the other notion in the area of ontology matching which is mainly oriented or 
directed version of an alignment. It maps the entities of one ontology to at most one 
entity of another ontology [60]. 
Ultimately, ontology merging is the creation of a new ontology from two, possibly 
overlapping, source ontologies. In this process the initial ontologies remain unaltered and 
the merged ontology is supposed to contain the knowledge of the initial ontology [65]. 
 
Figure 4.1: The Matching Process 
Ontology matching is the process of finding relationships or correspondences between 
semantically related entities of different ontologies [63]. These correspondences may 
stand for equivalence as well as other relations such as consequence, subsumption or 
disjointness between ontology entities [64]. Ontology entities usually denote the named 
entities of ontologies such as classes, properties or individuals. However, these entities 
can also be more complex expressions, such as formulas, concept definitions, queries or 
term building expressions [62, 66]. The matching process can be seen as a function f 
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which takes two ontologies o and o’ , an input alignment A, a set of parameters p, and a 
set of oracles and resources r, and returns an alignment A’ between o and o’ [63]: 
                 
The matching process is schematically represented in Figure 4.1. 
In this thesis ontology matching is applied to find the correspondences between entities 
of Drug Ontology and Human Disease Ontology. This process is fully described in 
section 4.3. 
4.2 Matching Techniques Classification 
There are various techniques for computing the matching process and there is still much 
work going on in finding better methods. Many different matching solutions have been 
proposed so far from various viewpoints such as databases, information systems and 
artificial intelligence. They take advantage of various properties of ontologies such as 
structures, data instances, semantics, or labels, and use techniques from different fields 
such as statistics and data analysis, machine learning, automated reasoning, and 
linguistics. These solutions share some techniques and tackle similar problems, but differ 
in the way they combine and exploit their results [62, 63, 64, 66]. Basically, matching 
techniques are categorized in two main groups of Element-level and Structure-level. In 
the following some of the most used techniques are classified. 
4.2.1 Element-level  
Element-level matching techniques calculate correspondences by analyzing entities or 
instances of those entities separately and do not pay attention to their relations with other 
entities or instances. Particularly, they are concerned about the entities or their instances 
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in isolation from their relations with other entities or their instances [61, 64]. Some of the 
known techniques that are based on Element-level are: String-based techniques, 
Language-based techniques, and Alignment reuse that are briefly described in the 
following. 
String-based techniques can be applied to compute string similarity between the ontology 
entities. The string may represent the names, name descriptions, the label or the 
comments of entities and treated as sequence of letters.  
String-based methods are normally based on the following intuition: the more similar the 
strings, the more likely they are to indicate the same concepts. String methods may use 
some functions to show the distance between a pair of strings, this distance is usually 
shown as a real number. The smaller value of the real number shows a greater similarity 
between the strings. String-based methods can easily find similar classes such as book 
and textbook but typically they will not be able to find book and volume as the similar 
classes. There are several software packages for computing string distances such as 
Simetrics1, Prompt, the Alignment API3 and SimPack4 [62-63]. 
Language-based techniques consider names as words in some natural language such as 
English. They take advantage of natural language processing techniques to help extract 
the meaningful terms from a text and based on that find the similarity between two 
strings as meaningful pieces of text rather than sequences of characters. Some of these 
methods may use the external resources, such as dictionaries, lexicons, thesauri to 
compute the similarities between terms. Perl package WordNet and the Java package 
SimPack apply these techniques to find the existing similarities [62-64]. 
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Alignment reuse techniques apply an alternative way of using external resources, which 
record alignments of previously matched ontologies. For instance, when we need to 
match ontology o and o”, we use the given alignments between o and o’ as an external 
resource to be available between o and o”. This method is based on this idea that most of 
ontologies to be matched are similar to already matched ontologies, especially if they are 
in the same application domain. COMA++ applies alignment reuse to find the similarities 
between entities [63]. 
4.2.2 Structure-level  
Compared with element-level techniques, structure-level techniques are concerned about 
the relations between the entities and their instances with other entities and their instances 
in the process of computing the correspondences. In fact, structure-level matching 
techniques compute correspondences by considering how entities or their instances 
appear together in a structure [61, 64]. Graph-based techniques, Taxonomy-based 
techniques, and Model-based techniques are some of known methods that are based on 
Structure-level techniques. They are explained in brief in the following paragraphs. 
Graph-based techniques are based on relational structure which allows all the relations 
between entities to be taken account. Ontology can be considered to be a graph whose 
edges are labeled by relation names. Finding the correspondences between elements of 
such graphs corresponds to solving a form of the graph homomorphism problem. 
Usually, the similarity comparison between a pair of nodes from the two ontologies is 
based on the analysis of their positions in the graphs. The idea behind this is that, if two 
nodes from two ontologies are similar, their neighbors must also be somehow similar. 
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Kang&Naughton can be named as an example of a system that applies this technique 
[63]. 
Taxonomy-based techniques are also based on graph algorithms; however consider only 
the specialization relation. Taxonomic techniques idea is that is-a links connect concepts 
that are already similar (being taken as a subset or superset of each other), therefore their 
neighbors may be also somehow similar. Prompt and OLA are two systems that use this 
technique [62-63]. 
Model-based algorithms manage the input based on its semantic interpretation. The idea 
is that if two entities are the same, then they share the same interpretations. They are 
deductive methods; hence they do not perform very well alone for an essentially 
inductive task like ontology matching. An important challenge of these techniques is their 
combination with inductive techniques. S-Match and CtxMatch use the semantic methods 
to find similar correspondences [62-64]. 
Prompt Suite is applied in this work to perform the matching process employs string-
based techniques to find the correspondences between the entities of Drug and Human 
Disease Ontology. This is explained in detail in section 4.3. 
4.3 Prompt Suite 
In this section Prompt Suite is introduced. This Suite is applied in this thesis to perform 
ontology matching. Among other available tools and environments dealing with ontology 
matching, Prompt is selected due to a good quality of its suggestions [42, 65, 67]. Based 
on the research that was done [42, 65, 67], human experts accepted 90% of Prompt’s 
suggestions and 75% of the conflict-resolution strategies that Prompt proposed. 
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The Prompt Suite is an interactive framework for comparing, matching, merging,   
maintaining versions, and translating between different knowledge representations. It is 
introduced as a plug-in for Protégé. Prompt allows managing multiple ontologies in 
Protégé. Prompt takes two ontologies as input and leads the user in the construction of 
combined ontology as output. In the first step, Prompt computes an initial set of matches 
based on lexical similarity between class names which is based on string-based 
technique. The rest of the process go on the following cycle: First, user picks an 
operation to perform, either by selecting one from the Prompt suggestion list or specifies 
the desired operation directly via ontology-editing environment. Then, Prompt performs 
the operation chosen by user. It automatically identifies inconsistencies, such as name 
conflicts, redundancy in the class hierarchy, and suggests possible strategies to resolve 
them. Finally, it generates a list of suggestions for users [42, 63, 65, 67]. Figure 4.2 
shows the flow of Prompt Algorithm, in which the pink box indicates the action that is 
performed by the user and the blue boxes refer to actions that are executed by Prompt. 
In this thesis the extract option of Prompt Tab is used to create the upper level Disease-
Drug Ontology from the two main Drug and Human Disease Ontologies. Extract option 
which is based on ontology matching, allows us to move desired part of drug ontology to 
our disease ontology which can lead to reduce the size of ontology and increase the 
efficiency of the final result; however the information that are not transferred can be 
added to the system any time that is required. By matching each class of Drug Ontology 
into the Human Disease Ontology, all the properties and slots that are related to that class 
are also transferred to the ontology.  
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Figure 4.2: The flow of Prompt Algorithm 
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This Chapter describes OWL-DL reasoning as well as rules and ontology reasoning. It 
first presents the process of reconciliation and validation of DDO via a Description Logic 
Reasoner. Afterward, it describes the notion of ontology crawler and how it provides 
physicians by direct queries from DDO to facilitate the decision making for correct drug 
recommendation. This Chapter comes to an end with the discussion about the rule-based 
inference engine and the relevant rules that are required to infer the correct results for the 
drug recommendation system.  
5.1 Pellet Reasoning 
Like any Semantic Web framework, the DDO involves knowledge components from 
multiple sources which may introduce inconsistencies that demands reconciliation and 
validation [68]. The DDO is formalized in OWL-DL which has foundation for reasoning 
based on Description Logics. Thus, it is feasible to perform automated reasoning over the 
ontology using a Description Logic reasoner [29]. A Description Logic reasoner presents 
a variety of inference services. One of the main services offered by a Description Logic 
reasoner is to determine whether or not a class is consistent. A class is called inconsistent 
if it cannot possibly have any instances. Ability to compute inferred instances is another 
standard service that is offered by a reasoner. Furthermore, a Description Logic reasoner 
is capable, for instance, to check whether or not a class is a subclass of another. By 
performing such a test on the classes of ontology, a reasoner would be able to compute 
the inferred ontology class hierarchy. Being able to use a reasoner to automatically 
compute the class hierarchy is one of the major benefits of building an ontology using the 
OWL-DL sub-language. Indeed, in construction of very large ontologies with several 
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thousand classes, the use of a reasoner to compute subclass-super class relationships 
between classes becomes vital. Without a reasoner it is very difficult to keep large 
ontologies in a maintainable and logically correct state. Computing and maintaining 
multiple inheritances are also done by the reasoner. This technique helps to keep the 
ontology in a maintainable and modular state. This does not only promote the reuse of the 
ontology by other ontologies and applications, it also minimizes human errors that are 
inherent in maintaining a multiple inheritance hierarchy [29, 69, 70]. 
In this thesis, Pellet 1.5.2 is utilized to validate the ontology framework that is generated. 
Pellet reasoner is an open-source Java based OWL-DL reasoner that can be used in 
conjunction with both Jena and OWL API Libraries. For systems applying OWL to 
represent information, Pellet is the leading choice where sound and complete OWL-DL 
reasoning is essential [29, 43, 71]. In this study Pellet is used as a direct reasoner which 
can be set up as an additional plug-in for Protégé 3.4 and be invoked from Protégé by 
calling directly the reasoner API.  The Pellet uses the methods of Check Consistency, 
Classify Taxonomy, and Compute Inferred Types to evaluate the ontology. The result of 
employing Pellet reasoner indicates that DDO is consistent and computes its inferred 
types. However, four classes are detected to have more than one super class in DDO 
hierarchy. We have examined and resolved each of them by eliminating redundancies or 
redefining restrictions. Therefore, after reclassifying and applying the inferred hierarchy 
suggestions, the general processing time for Pellet reasoner to process the DDO takes less 
than 163 seconds which is shown in Figure 5.1. Green dots denote the items that are 
checked and validated. 
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Figure 5.1: OWL-DL Reasoning Log of Finalized DDO by Pellet Reasoner 
5.2 Disease-Drug Ontology Crawler 
Disease-Drug Ontology Crawler provides physicians with essential queries to choose 
pertinent drugs and make a suitable decision for drug recommendation. DDO Crawler is 
comprised of DDO itself, and Jena API which is a Java framework for developing 
semantic web application. Jena Framework is a widespread open-source project and 
stable API that has been broadly applied in an extensive range of semantic web 
applications. It includes an Ontology API for handling OWL and RDFS ontologies and 
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also a query engine in order to support direct queries from ontologies. Furthermore, it 
provides a wide variety of Java Libraries to aid developers with writing Java codes that 
handle ontologies [72-74]. In this thesis Jena is employed as a query engine to read the 
Disease-Drug Ontology and to act as Ontology API between DDO and Java framework. 
Eclipse SDK 3.3.1 is used as the Java development platform.  
Initially, in Jena all the information are encoded as RDF triples and stored in the RDF 
Model. Thus, in order to work with ontologies that are defined in OWL, Jena as an 
Ontology API offers the concept of ontology model which is an extended version of Jena 
RDF model. Ontology model provides additional capabilities for handling ontologies 
such as adding extra supports for some sort of concepts expected to be in an ontology 
including classes, properties and individuals. Ontology models are built through Jena 
ModelFactory class. The default setting of creating ontology model is defined for 
ontologies in OWL-Full. Therefore, in order to create an ontology model for ontologies 
that are constructed in other languages, OntModelSpec object is also required to be 
applied. This specification allows complete control over the configuration choices for the 
ontology model [72-74]. The following code creates an ontology model with 
specifications of OWL-DL language and in-memory storage that is used in this thesis.  
OntModel m = ModelFactory.createOntologyModel(OntModelSpec.OWL_DL_MEM); 
 
Each ontology model has a correlated document manager which supports for the 
processing and handling of ontology documents. Besides, the read method is applied to 
load an ontology document into an ontology model. Several variants can be defined on 
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read to handle different sources of document such as URL, local location or an input 
stream. The DDO is loaded into the ontology model through following codes which 
indicates that is located locally on disk. 
m.getDocumentManager().addAltEntry(null,"c:/Namira/Thesis/DDO/DDO.owl"); 
m.read("file:/C:/Namira/Thesis/DDO/DDO.owl") ; 
 
After loading DDO into the ontology model, understanding of classes and its related 
concepts in the Ontology API is required to aid programming of desired queries. All of 
the classes in the Ontology API that stand for ontology values share OntResource as a 
common super class. Therefore, all shared functionality for such classes can be placed in 
OntResource. Since the Java interface OntResource extends Jena’s RDF Resource 
interface, any general method that accepts a resource will accept an ontResource, and 
consequently, any other ontology value as well. Label, sameAs and differentFrom can be 
named as some of common attributes of ontology resources. These attributes can be 
expressed through methods on OntResource. Some of standard pattern of these methods 
are including: add, set, list, get, has and remove. For example getLabel(“”) returns that 
human-readable label of the respective class or the values of a named property can be 
listed with listPropertyValues( ). Besides, each simple class is represented in Jena by an 
OntClass object. In other words, Jena converts Ontology classes into objects of type 
OntClass. Thus OntClass allows accessing all the information in an ontology class. Once 
the ontology class object is defined, it can be processed through the methods defined on 
OntClass. The properties of a class are handled through similar methods that are 
mentioned on OntResource. Some properties of classes that are expressed in this way are: 
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subClass, superClass, equivalentClass, disjointWith and instances. As an example we can 
print a list of instances of Drug Class of DDO as follows (cls is an Ontclass object that 
points to Drug Class): 
protected void getDrugInstance(OntClass cls){ 
       
ExtendedIterator<? extends OntResource> instances = cls.listInstances(); 
        
  while(instances.hasNext()) { 
         
      System.out.println("Instances of Drug Class = " +    
 
            instances.next().getLocalName()); 
 
        } 
} 
 
Our system considers 9 following inquiries to query DDO : 
1 - Get Drugs of Diseases Query 
2 - Get Brands of Drugs Query 
3 - Get Drug interactions of Drugs Query 
4 - Get Food interactions of Drugs Query 
5 - Get Synonyms of Drugs Query 
6 - Get Side effects and Toxicity of Drugs Query 
7 - Get Indication of Drugs Query 
8 - Get Prices of Drugs Query 
9 - Get Manufacturers of Drugs Query 
 
These queries are programmed in Java framework and the information to respond to these 
queries are retrieved from DDO through Jena API. These direct queries can act as a 
significant aid for physicians to make more precise and appropriate decision to 
recommend drugs for diseases. Besides, the physicians can be informed about the current 
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prices, brands and manufacturers of Drugs by performing the relevant queries. The results 
of the queries are indicated in Chapter 6 of this thesis.  
5.3 Rule Engine Reasoning 
The Semantic Recommender System is the fundamental system component of our 
proposed model. This module is composed of a unique rule-based inference engine 
employing Drug Rules in conjunction with Disease-Drug Ontology and relevant medical 
facts. The rule engine produces the inference process to offer the clinicians proper 
consultations. In our proposed model, the knowledge in the DDO and other pertinent 
medical facts that may be created or updated by physicians are transformed into Drug 
Rules to feed the rule engine. Besides, the rule engine receives patient data from patient 
database; afterwards, it proposes a drug recommendation based on available data and 
rules. The drug recommendation includes generic name of drugs, proper doses based on 
the patient’s conditions and warning about any interaction between the recommended 
medication and the ones that patient is using.  
In this thesis OpenRules rule engine is used to carry out the inference process and lead to 
the drug recommendation. OpenRules provides an open source rule engine for rules-
based web application development. It is mainly based on widespread used tools 
including MS Excel and Eclipse IDE and is created to maintain complex decision support 
systems which proficiently execute various set of rules and methods. In contrast with 
other rule engines, OpenRules proposes to apply Excel directly as the Rules Repository 
and Management Tool. Such a specification allows non technical users, who may not 
have any knowledge of coding, such as physicians, to be able to modify or update the 
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rules directly in Excel after the initial implementation of the system. Furthermore, 
OpenRules approach applies Eclipse as a powerful IDE for rule integration within a java-
based development environment. Practically, Eclipse offers the control mechanism for 
Excel-based rules and is applied for code editing, debugging and testing of rule projects. 
OpenRules also supports implementation of a web-based graphical user interface (GUI) 
via Apache Tomcat Java Servlet. Moreover, its libraries allow defining layouts of web 
pages and relationships among them directly in Excel.  Such a powerful combination of 
Excel, Eclipse and OpenRules libraries and tools forms a practical framework for Rules 
Management and Web Application Development [75]. Figure 5.2 shows the OpenRules’ 
rules repository and its supporting tools.  
 
Figure 5.2: OpenRules’ Rules Repository and Supporting Tools  
As mentioned above, OpenRules utilizes Excel’s workbooks to represent and maintain 
rules and web forms. Each workbook is comprised of one or more worksheets in order to 
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separate information by categories and each worksheet includes one or more tables. Some 
of the typical types of tables that are supported by OpenRules are including: Decision, 
Form Layouts, Data and Datatypes, Methods and Environment tables.  
The most common way to indicate a set of rules is Decision tables. They are employed to 
express and evaluate various decision situations, where the state of a number of 
conditions resolves the execution of a set of actions. The execution logic of one rule 
which points to one row in the decision table is as follows:  
IF all conditions are satisfied THEN execute actions 
Therefore, actions are executed if all conditions in the same row are assessed to be true. 
An empty condition cell means that condition is always true. Three decision tables that 
are constructed for this thesis are recommendTherapy, recommendDose and 
drugInteraction that are displayed in Figure 5.3, 5.4 and 5.5, respectively. These tables 
are placed in three different worksheets that are located in HealthCareRules.xls 
workbook. The rules in the above tables are constructed based on the knowledge in DDO 
and the medical facts that are extracted from an accepted drug guide in medicine [76].  
HealthCareRules Workbook also contains another worksheet that includes a method table 
to implement the formula for creatinineClearance, for instance.  Creatinine Clearance 
level is a useful measure for indicating the state of kidney functionality which is a 
significant factor in medicine for recommendation of some specific drugs [76, 77]. 
Creatinine Clearance is calculated through following formula [76]:   
Creatinine Clearance = [[140 – age (yr)]* weight (kg)] / [72* Creatinine Level] 
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The method table that computes creatinineClearance is shown in Figure 5.6. 
 
Figure 5.3: Recommend Therapy Decision Table 
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Figure 5.4: Recommend Dose Decision Table 
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Figure 5.5: Drug Interaction Decision Table 
 
 
Figure 5.6: Creatinine Clearance Method Table 
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In order to run the OpenRules engine, it is required to create a main method that is 
defined particularly for the engine run. The main method of our work is denoted in the 
HealthCareMain.xls workbook as shown in the Figure 5.7. In the same work sheet 
another method is created with the purpose of validation of Creatinine level that is used 
in the computation of Creatinine Clearance Formula which is displayed in Figure 5.8. 
 
Figure 5.7: Main Method Table 
 
 
Figure 5.8: Validate Creatinine Level Method Table 
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When OpenRules engine runs, it downloads the main xls file and any other files and 
libraries that are defined in the main.xls file. Thus, to make references to our additional 
Excel files and libraries, making an Environment table in the main workbook is essential. 
This table, shown in Figure 5.9, allows the engine to download all other files using the 
include properties and recognize the other application files that the system is connected to 
such as relevant java files or Tomcat libraries. 
 
Figure 5.9: Environment Table 
In this thesis, a web-based GUI via Apache Tomcat 6.0 is implemented to communicate 
with the user and present the results of our rules. OpenRules provides a library called 
Forms that allows defining layouts of web pages and relationships among them directly 
in Excel as Layout tables.  Figure 5.10 indicates the Layout tables that are designed to 
define 3 web forms of VisitInformation, PatientInformation and Recommendations. To 
facilitate the navigation from one form to another, two buttons of Next and Prev are 
added at the top of each form. Moreover a Refresh button is implemented in the 
PatientInformation page to let recalculation of the Creatinine Clearance value whenever 
is needed. Figure 5.11 displays the processingFlowRules and nextLayout tables that are 
created to establish the relationship among the 3 web pages. All of the above tables are 
built in the HealthCareForms.xls workbook.   
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Figure 5.10: Layout Tables of Web Pages 
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Figure 5.11: Processing Flow Rules and Next Layout Tables 
 
The OpenRules engine receives patient information from a patient database. To prototype 
our work, a sample of patient database is created in order to test the system which is 
illustrated in Figure 5.12. This database is built in Access 2007 and is connected to the 
rule engine through some coding in java framework. The results of reasoning via rule 
engine are demonstrated in Chapter 6 of this thesis. 
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Figure 5.12: A Sample of Patient Database
  
CHAPTER 6 
CASE STUDIES 
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This Chapter portrays the operational environment of the developed system. The results 
of methodologies associated with semantic characteristics and techniques for drug 
recommendation, including ontology query and semantic inference are described. For 
each method, some scenarios are provided to prototype the main system services and 
demonstrate the validity of our semantically integrated Disease-Drug knowledge base. 
 6.1 Query Engine Results 
As mentioned in Chapter 5, our system provides physicians with some essential direct 
queries that can be made from DDO through Java framework and Jena API. Moreover, 
these queries are applied to illustrate the validity of our semantic disease-drug knowledge 
base as well as experiment with semantic web techniques. In this practice, we have 
conducted a series of questions and issues that are usually faced with therapeutic cases. 
The particular questions to be answered are what are the typical drugs for the diseases 
and their relevant features including various prices, possible side effects, accessible 
brands, applicable synonyms, potential indications, multiple manufacturers and drugs or 
food that can interact with. Therefore, our system is capable of responding to nine 
significant queries regarding disease-drug knowledge base. 
The first step when the system runs is to select the desired query among nine queries that 
are shown previously in Chapter 5. Figure 6.1 and 6.2 display the results of the first query 
which retrieves the relevant drugs of a disease for Coronary Heart Disease and Diabetes 
mellitus type 2. To retrieve the typical drugs of these diseases, initially the system looks 
for the class of desired disease in DDO. Then it acquires and returns the labels of the drug 
classes that are in a relationship with this disease class through may treated by property. 
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Figure 6.1: Retrieved drugs from DDO for Coronary Heart Disease 
 
 
Figure 6.2: Retrieved drugs from DDO for Diabetes mellitus type 2 
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In order to obtain the brands of one specific drug, first the system seeks for the class of 
listed drug in DDO. After that, it finds the brandsSlot property of the determined drug 
class and obtains the object of data type property, then returns it as a String. As an 
example the accessible brands of Metoprolol and Metformin are shown in Figure 6.3. 
 
Figure 6.3: Obtained brands of Metoprolol and Metformin from DDO 
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The rest of the queries follow similar process as the previous one that by obtaining the 
desired drug class, the relevant Slot property is found and the object of data type property 
of that slot is returned as a String. In the following, separated examples are provided for 
each of the queries. Metoprolol and Metformin are two drugs that are applied in these 
examples to run the queries. The possible drug interactions and food interactions of 
Metoprolol and Metformin are displayed in Figure 6.4 and Figure 6.5 respectively.  
 
Figure 6.4: Possible Drug Interactions for Metoprolol and Metformin 
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Figure 6.5: Possible Food Interactions for Metoprolol and Metformin 
Figure 6.6 shows the applicable synonyms of Metoprolol and Metformin. 
 
Figure 6.6: Appropriate Synonyms for Metoprolol and Metformin 
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Correspondingly, the possible side effects and potential indications of Metoprolol and 
Metformin are demonstrated in Figure 6.7 and Figure 6.8. 
 
Figure 6.7: Probable Side Effects and Toxicities for Metoprolol and Metformin 
 
Figure 6.8: Feasible Indications for Metoprolol and Metformin 
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A variety of prices for Metoprolol and Metformin are retrieved through query 8 which is 
displayed in Figure 6.9. 
 
Figure 6.9: Available Prices for Metoprolol and Metformin 
Several manufacturers for Metoprolol and Metformin are acquired through query 9 which 
is exemplified in Figure 6.10. 
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Figure 6.10: Different Manufacturers for Metoprolol and Metformin 
6.2 Drug Recommendation System Results  
In this Section the final results of drug recommendation system is exemplified through 
diverse case studies. These results are achieved by applying RecommendTherapy Rules, 
RecommendDose Rules and DrugInteaction Rules which are described in Chapter 5. 
OpenRules engine employs above rules to infer the appropriate drug recommendation 
results based on the available facts and presented data. Obtainable data from patient 
database is employed to feed the rule engine. The system communicates with physicians 
through three pages of Visit Information, Patient Information and Recommendations 
which are displayed via GUI that is associated with OpenRules engine. In the Visit 
79 
 
Information form, name of the desired patient and the disease that is diagnosed for the 
patient is entered by the physician. Visit date is programmed to display the current date of 
visit. Based on the name of the patient, the medical history of patient is retrieved from 
patient database and presented in the next form which is Patient Information. However, 
the system also allows the physicians to make changes to some of this information where 
it is required. As an example the physician is able to change the amount of current 
patient’s weight if it differs from the one that is stored in the database. In such a case, the 
amount of Creatinine Clearance needs to be recalculated by pushing the refresh button, as 
well. Finally, the results of drug recommendation are indicated in the third form that is 
called Recommendations. Following case studies present the usability and capability of 
the drug recommendation system in making distinct decisions based on the various 
circumstances and conditions. 
In the first case study, we assume Shawn Dalton and John Smith as the patients who are 
diagnosed with Acute Sinusitis. And then we investigate the results of drug 
recommendation system based on their medical information and distinct rules that should 
be applied to their cases.  Let’s start our experiment with Shawn’s information. The Visit 
Information for Shawn Dalton is displayed in Figure 6.11(a). Shawn Dalton’s medical 
information that is retrieved from patient database is shown in the Patient Information 
form which is illustrated in Figure 6.11(b). Since Shawn is older than 18 and does not 
have any allergy to Penicillin, the system recommends Amoxicillin as a suitable drug for 
him based on the RecommendTherapy Rules. Based on the RecommendDose Rules, 
500mg every 24 hours for 14 days is suggested as the appropriate dose because his age is 
between 15 and 60 and the amount of his Creatinine Clearance is more than 50. The 
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recommended drug, Amoxicillin, does not have any interaction with his active 
medication, Insulin Glargine based on the DrugInteraction Rules. Hence, the system does 
not show any warning. The recommendations for Shawn are illustrated in Figure 6.11(c). 
The Visit Information of John Smith who is another patient with the Acute Sinusitis 
diagnosis is shown in Figure 6.12(a). From his medical information that is displayed in 
Figure 6.12(b), it is realized that he has allergies to Penicillin and Streptomycin and his 
active medication is Coumadin. Although his age is more than 18 like Shawn, he is not 
able to use Amoxicillin due to his allergy to Penicillin. Therefore, based on the 
RecommendTherapy Rules, our system proposes Levofloxacin as the alternative drug. 
Based on John’s age and the amount of his Creatinine Clearance the same dosing rule as 
Shawn’s case is also applied to his. Thus, 500mg every 24 hours for 14 days is 
recommended for John, as well. Ultimately, the proposed medication, Levofloxacin, 
shows some sort of interaction with Coumadin, a medication that John is currently on, 
based on the DrugInteraction Rules. Therefore, system shows warning for the interaction 
that may happen due to concurrent consumption of these two medications. The 
appropriate drug recommendation for John is displayed in Figure 6.12(c). 
The outcome of this case study demonstrates how our proposed system is capable to 
apply proper rules and suggest different recommendations that are suitably based on the 
patients’ allergies and active medications. 
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a 
b 
c 
Figure 6.11: (a) Visit Information form of Shawn Dalton. (b) Patient Information form of 
Shawn Dalton. (c) Drug Recommendations for Shawn Dalton  
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a 
b 
c 
Figure 6.12: (a) Visit Information form of John Smith. (b) Patient Information form of 
John Smith. (c) Drug Recommendations for John Smith  
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In the second case study, three patients who are diagnosed with Coronary Heart Disease 
are used as our experimental cases. This case study shows the ability of our system to 
recommend appropriate drug doses depends on the amount of Creatinine Clearance and 
age of patient. Three patients that are retrieved from patient database are: Isabella More, 
Anthony Sanchez and Maria Lee. The Visit Information for each of them is displayed in 
Figure 6.13(a), 6.14(a) and 6.15(a), respectively. Based on the RecommendTherapy 
Rules, the same rule is applied in order to suggest proper medications for all three used 
patients. As a result, a set of drugs including: Asa, Metoprolol, Heparin, Lovastatin, 
Perindopril and Clopidogrel are recommended as the suitable medications for all of them 
that are diagnosed with Coronary Heart Disease.   After that, system looks for Dosing 
Rules in RecommendDose Rules table to advocate the correct drug doses for each patient. 
From Isabella’s medical Information, it is realized that she is 32 years old and the amount 
of her Creatinine Clearance is more than 30. Hence, the dosing rule that is relevant to 
patients older than 17 is considered for her.  Figure 6.13(b) points to Isabella’s 
information. Anthony who is just 12 years old is included in another category of dosing 
rules which is suitable for patients younger than 17. Anthony’s relevant Patient 
Information form is illustrated in Figure 6.14(b). Although Maria is older than 17 like 
Isabella, the dosing rule that is applied to her case differs from Isabella’s. The system 
allocates another dosing rule to Maria’s case due to the amount of Maria’s Creatinine 
Clearance which is less than 30. Figure 6.15(b) illustrates Maria’s medical information. 
Based on the DrugInteraction Rules, the system reveals an interaction between one of 
Isabella’s active medications, Triamterene and Perindopril which is one of the 
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recommended drugs for her. This is illustrated in the list of recommendations for her in 
Figure 6.13(c).  
 
 
a 
b 
c 
Figure 6.13: (a) Visit Information form of Isabella Moore. (b) Patient Information form 
of Isabella Moore. (c) Drug Recommendations for Isabella Moore 
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In Anthony’s recommendation form which is shown in Figure 6.14(c), no warning is 
displayed since he is not on any other drugs. 
 
a 
b 
c 
Figure 6.14: (a) Visit Information form of Anthony Sanchez. (b) Patient Information form 
of Anthony Sanchez. (c) Drug Recommendations for Anthony Sanchez 
86 
 
 
a 
b 
c 
Figure 6.15: (a) Visit Information form of Maria Lee. (b) Patient Information form of 
Maria Lee. (c) Drug Recommendations for Maria Lee 
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Ultimately, as Maria’s recommendation form is displayed in Figure 6.15(c), the system 
warns an interaction between her active medication, Cimetidine and Metoprolol which is 
one of the recommended drugs for her.  
Consequently, these case studies indicate the novelty of our approach to facilitate precise 
and reliable drug recommendations by considering various medical variables and 
diversity of patients’ situations by applying suitable rules to the rule engine.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
CHAPTER 7 
CONCLUSION & FUTURE WORKS 
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In this thesis, a drug recommendation system based on the Semantic Web standards and 
technologies has been proposed to aid physicians and pharmacists in making the right 
decision in selecting suitable medications for the diagnosed diseases. Our approach in 
this work offers a flexible and powerful framework to achieve this by providing solutions 
for knowledge representation in the domains of drugs and diseases based on their clinical 
and therapeutic aspects. The concept of ontology has been utilized in constructing a 
comprehensive knowledge framework across drugs and diseases. We perceive our 
proposed ontology as one of the pioneering ontologies which gathers both domains of 
drugs and diseases in one umbrella based on the therapeutic aspects of drugs and 
diseases.  The DDO constructed in this thesis provides a reasonably unrestrictive 
framework with suitable conceptualization level that allows for a unified reasoning. 
Using the dependable and authentic ontologies and data bases in developing DDO 
supports the extensibility and adaptability of the system in future developments. The 
novelty of our proposed system is that it not only integrates reliable knowledge sources 
for the disease and drug entities, but it also overcomes the heterogeneity among these 
sources by applying appropriate matching techniques. As DDO has been implemented in 
OWL-DL, the process of reconciliation and validation of that has been performed 
through a Description Logic Reasoner. In particular, a query engine which has been 
assembled in the ontology crawler provides physicians with essential direct inquiries 
from DDO. Moreover, the outcome of our work has been specifically extended by 
employing a unique rule-based inference engine which carries out the inference process 
and leads to the acceptable drug recommendation. The case studies provide valuable 
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insights of the operational environment of the developed system and show the uniqueness 
of our method in facilitating the detection of reliable drug recommendations.  
This research can be expanded in several ways. In this thesis, the relationship between 
eleven diseases and their applicable drugs which are seventeen has been built. In order to 
transform this system to a more realistic one, a detailed relationship among the diseases 
and their relevant drugs needs to be created in the future. Furthermore, to raise the 
usability and reliability of our drug recommendation system, more specific drug rules 
such as any interaction of recommended drugs with pregnancy, life style and herbs can be 
combined to the system. Another possible extension is the use of data mining techniques 
to offer prognostic drug recommendations in addition to the rule-based inference engine 
system that is created in this thesis. Data mining techniques evaluates preceding available 
cases to anticipate the drug recommendations of new cases. Comparing the drug 
recommendation results from data mining techniques with the ones coming from rule 
engine could bring up more controversial discussion or more accurate, dependable 
results. 
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